Summary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Cause
-
-
Agrochemicals
Cipla launches ‘Spirofy’, Pneumotach-Based Portable Wireless Spirometer for Early Diagnosis of COPD
by adminby adminKEYPOINTS: Spirofy is India’s first pneumotach-based portable wireless Spirometer for the diagnosis of COPD and asthma. The company intends with this launch…
-
AstraZenecaDapagliflozin
NICE issues Draft Recommendation for AstraZeneca`s Forxiga (Dapagliflozin) to Treat Adults with Chronic Kidney Disease
by adminby adminAbstract: The National Institute for Health and Care Excellence (NICE) has issued an Appraisal Consultation Document (ACD) for AstraZeneca’s Forxiga (Dapagliflozin) within…